A physician-scientist at Mayo Clinic is drawing on brain tissue samples, genomic data and patient records to find new ways to diagnose and treat Alzheimer’s disease.
Nilüfer Ertekin-Taner, M.D., Ph.D., is combining three distinct sources of information — Mayo Clinic’s brain bank, genomic data, and direct patient insights — to identify new paths toward understanding Alzheimer’s disease. Her stated goal, according to the Mayo Clinic post, is more precise care for every patient.
The work sits at the intersection of laboratory science and clinical medicine. Brain banks hold donated tissue that researchers can study after death, while genomic data maps the genetic material that may influence who develops the disease and how it progresses. Layering patient insights on top of both allows researchers to connect biological findings to real-world experience.
Alzheimer’s disease is the most common form of dementia (a condition that affects memory, thinking and behaviour). The NHS describes it as a progressive condition, meaning symptoms worsen over time.
Ertekin-Taner’s approach reflects a broader shift in dementia research toward understanding why the disease affects people differently — and whether treatment can be tailored rather than applied in the same way to everyone.
If you are concerned about memory problems in yourself or someone you know, contact your GP in the first instance. NHS 111 is available by phone or online for non-emergency health queries. The Alzheimer’s Society helpline can be reached on 0333 150 3456.
Source: @MayoClinic